Posts tagged CardiAQ
Echelon ups Neovasc price target to $3.25

Echelon Wealth Partners raised its price target for Neovasc (NASDAQ:NVCN) to $3.25 from $1.25 after the company sold its PeriPatch processing operations to Boston Scientific (NYSE:BSX). The stock closed at 86 cents on Dec. 2.

Read More